Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uterine Carcinosarcoma
|
80 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Undifferentiated (Embryonal) Sarcoma
|
4 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
Transitional cell carcinoma of bladder
|
158 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Squamous cell carcinoma of the head and neck
|
348 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Squamous cell carcinoma of lung
|
283 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Squamous cell carcinoma of esophagus
|
329 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Serous cystadenocarcinoma ovary
|
99 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Sarcoma of liver
|
1 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
Primary malignant neoplasm
|
1374 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
ovarian neoplasm
|
757 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 0 | |||||||||
Neoplastic Syndromes, Hereditary
|
6387 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 30 | 1990 | 2017 | ||||||
Neoplasms
|
1644 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.740 | 1.000 | 6 | 2006 | 2018 | ||||||
Microvascular Angina
|
10 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Mammary Neoplasms
|
385 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant Neoplasms
|
1641 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Malignant neoplasm of liver
|
88 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Liver carcinoma
|
942 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Liver and Intrahepatic Biliary Tract Carcinoma
|
73 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Li-Fraumeni-Like Syndrome
|
8 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 0 | |||||||||
LI-FRAUMENI SYNDROME 1
|
39 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 19 | 1992 | 2016 | ||||||
Li-Fraumeni Syndrome
|
206 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.810 | 1.000 | 52 | 1990 | 2017 | ||||||
Glioma
|
353 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Glioblastoma
|
281 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Gastric Adenocarcinoma
|
235 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Esophageal carcinoma
|
272 | 0.641 | 0.400 | 17 | 7674230 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 |